Aion Therapeutic Inc.
AION
CNSX
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.60% | 34.76% | 24.14% | 81.98% | 78.26% |
| Total Depreciation and Amortization | -21.68% | -81.51% | -76.72% | -74.95% | -79.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 113.15% | 29.13% | 1,986.68% | -108.96% | -92.57% |
| Change in Net Operating Assets | -19.30% | -62.29% | -67.45% | -45.35% | 27.26% |
| Cash from Operations | 161.77% | -47.33% | 82.67% | 96.86% | 91.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -241.26% | -347.21% | -96.92% | 12,637.50% | 181.65% |
| Total Debt Issued | -88.32% | -95.18% | -85.19% | -64.89% | -49.10% |
| Total Debt Repaid | 92.94% | -192.98% | -121.19% | 69.18% | 75.61% |
| Issuance of Common Stock | 442.60% | 442.60% | -- | -91.01% | -94.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 140.93% | -10.93% | -48.81% | -86.86% | -87.61% |
| Foreign Exchange rate Adjustments | 65.60% | 82.20% | -109.94% | -170.08% | -246.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28,833.33% | -527.27% | 75.10% | 100.41% | 99.57% |
